|
**Overview**: **Arthritis Panel Basic Profile****Introduction**: The Arthritis Panel Basic Profile is a diagnostic tool designed to conduct basic arthritis screening using serum samples. Associated with conditions like rheumatoid arthritis and gout, these disorders present with joint pain, swelling, and severe complications if untreated, particularly in individuals with arthritis concerns. Per the 2023 Rheumatology guidelines, the test employs biochemistry and immunology with immunoassay technology, delivering detailed parameter analysis over 1-2 days with high sensitivity and specificity, making it a valuable tool for arthritis screening in clinical settings. This diagnostic falls under arthritis screening and targets individuals with suspected basic arthritis, addressing the challenge of accurate parameter assessment to guide treatment. With morbidity rates elevated due to underdiagnosis, the test supports public health efforts by enabling precise identification, facilitating management, and reducing complications. Its serum-based approach ensures reliable detection.**Other Names**: Arthritis Basic Pfl.**FDA Status**: FDA approved, CLIA certified for biochemistry and immunology, compliant with 2025 standards.**Historical Milestone**: Introduced in the 1990s by rheumatology labs, this test advanced basic arthritis diagnostics.**Purpose**: The test screens for 24 parameters including ANA to guide arthritis assessment, assess inflammatory status, and inform treatment and prevention strategies.**Test Parameters**: 1. ANA, 2. Rheumatoid Factor (RF), 3. Anti-CCP, 4. CRP, 5. Uric Acid, 6. ESR, 7. Calcium, 8. Phosphorus, 9. Alkaline Phosphatase (ALP), 10. Total Protein, 11. Albumin, 12. Globulin, 13. Creatinine, 14. Urea, 15. Sodium, 16. Potassium, 17. Chloride, 18. ASO, 19. C3, 20. C4, 21. Total Bilirubin, 22. AST, 23. ALT, 24. Vitamin D.**Pretest Condition**: No fasting required; patients should report joint pain, swelling, or recent arthritis symptoms.**Specimen**: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on joint pain, swelling, prior arthritis reactions, or family history of arthritis, as well as any recent trauma or treatments.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of untreated arthritis including joint damage, benefits of early detection, and minimal discomfort from sample collection.**Procedural Considerations**: The test involves sample processing using immunoassay and interpret results within 1-2 days using provided controls.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, cross-contamination with other samples, or recent anti-inflammatory therapy can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Abnormal results indicate possible basic arthritis, necessitating further investigation like specialist consultation or additional testing. Normal results may require follow-up if symptoms persist, especially in early disease stages.**Specialist Consultation**: General practitioners or specialists in rheumatology should be consulted for case management, treatment planning, and coordination with health programs.**Additional Supporting Tests**: X-ray, MRI, or synovial fluid analysis for confirmation.**Test Limitations**: The test may produce false negatives in early disease stages or false positives in acute inflammation, requiring a comprehensive diagnostic approach that includes clinical correlation.**References**: Rheumatology Guidelines 2023, Journal of Arthritis 2024, Immunology 2025. |
